Silicone Band Versus Prilocaine Spray for Lifelong Premature Ejaculation
NCT: NCT07820865 · COMPLETED
Brief Summary
This pilot study compared two approaches for men with lifelong premature ejaculation, a condition in which ejaculation occurs sooner than desired from the first sexual experiences and is difficult to delay. The aim was to explore their effects on ejaculation time, symptoms, treatment satisfaction, and side effects, and whether improvements persisted after treatment stopped. Thirty-two men aged 18-35 years were assigned by chance to use either a soft silicone band over the frenulum, the sensitive area on the underside of the head of the penis, or a prilocaine spray, a medicine that temporarily reduces sensation. Both treatments were used before or during intercourse as instructed for one month. Both groups also received guidance on techniques to help control ejaculation, including pausing stimulation and relaxation exercises. After the first month, participants stopped using the band or spray and continued the behavioural techniques alone for another month. Assessments took place at the start of the study and after one and two months. Participants estimated their average time from vaginal penetration to ejaculation and completed a questionnaire about premature ejaculation symptoms. Treatment satisfaction, treatment experience, and side effects were also assessed.
Frequently Asked Questions
What is Silicone Band Versus Prilocaine Spray for Lifelong Premature Ejaculation?
Silicone Band Versus Prilocaine Spray for Lifelong Premature Ejaculation is a clinical trial registered under NCT07820865. Current status: COMPLETED.
What is the status of NCT07820865?
The current status of NCT07820865 (Silicone Band Versus Prilocaine Spray for Lifelong Premature Ejaculation) is: COMPLETED.
When did Silicone Band Versus Prilocaine Spray for Lifelong Premature Ejaculation start?
Silicone Band Versus Prilocaine Spray for Lifelong Premature Ejaculation started on 2025-09-15.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.